التفاصيل البيبلوغرافية
| العنوان: |
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors |
| المؤلفون: |
Hoogenkamp, Denise S., de Wit–van der Veen, Linda J., Huizing, Daphne M.V., Tesselaar, Margot E.T., van Leeuwaarde, Rachel S., Stokkel, Marcel P.M., Lam, Marnix G.E.H., Braat, Arthur J.A.T. |
| المساهمون: |
MS Endocriene Oncologie, Cancer, Researchgr. Nucleaire Geneeskunde, MS Radiologie |
| سنة النشر: |
2024 |
| مصطلحات موضوعية: |
Combination therapy, Neuroendocrine tumor, Peptide receptor radionuclide therapy, Radioembolization, Oncology |
| الوصف: |
Purpose of Review: To provide insights into the role of peptide receptor radionuclide therapy (PRRT) in patients with advanced neuroendocrine tumors (NET) and an overview of possible strategies to combine PRRT with locoregional and systemic anticancer treatments. Recent Findings: Research on combining PRRT with other treatments encompasses a wide variety or treatments, both local (transarterial radioembolization) and systemic therapies, chemotherapy (i.e., capecitabine and temozolomide), targeted therapies (i.e., olaparib, everolimus, and sunitinib), and immunotherapies (e.g., nivolumab and pembrolizumab). Furthermore, PRRT shows promising first results as a treatment prior to surgery. Summary: There is great demand to enhance the efficacy of PRRT through combination with other anticancer treatments. While research in this area is currently limited, the field is rapidly evolving with numerous ongoing clinical trials aiming to address this need and explore novel therapeutic combinations. |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
application/pdf |
| اللغة: |
English |
| تدمد: |
1523-3790 |
| العلاقة: |
https://dspace.library.uu.nl/handle/1874/452538Test |
| الإتاحة: |
https://dspace.library.uu.nl/handle/1874/452538Test |
| حقوق: |
info:eu-repo/semantics/OpenAccess |
| رقم الانضمام: |
edsbas.789D3283 |
| قاعدة البيانات: |
BASE |
